Nutex Health Inc.
NUTX
$123.54
-$16.97-12.08%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 295.13% | -58.56% | 89.54% | 92.93% | -114.33% |
Total Depreciation and Amortization | 12.77% | 4.77% | 8.72% | 4.82% | 43.12% |
Total Amortization of Deferred Charges | 667.78% | -24.45% | -77.39% | 5,349.25% | -102.15% |
Total Other Non-Cash Items | 34.71% | 1,401.29% | 477.84% | -326.45% | 569.39% |
Change in Net Operating Assets | -1,728.96% | -152.00% | 1,408.83% | -37.91% | -163.64% |
Cash from Operations | 103.01% | 244.94% | 107,704.88% | 190.01% | -139.42% |
Capital Expenditure | -147.86% | 78.54% | 81.82% | 83.25% | -89.52% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -145.66% | 92.62% | 58.65% | 86.46% | -89.02% |
Total Debt Issued | -71.89% | 141.81% | -81.13% | -61.65% | 143.31% |
Total Debt Repaid | 20.90% | 18.54% | 71.26% | -89.09% | -102.23% |
Issuance of Common Stock | -- | -- | -51.59% | 32,766.07% | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -12.84% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | 68.69% | -- |
Other Financing Activities | -216.12% | -9.00% | 30.70% | -- | 54.88% |
Cash from Financing | 23.71% | 90.16% | -139.96% | 93.07% | 73.47% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 31.02% | 202.93% | 13,240.63% | 664.21% | -103.96% |